Phase II Trial of Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
Most Recent Events
- 19 Sep 2024 Status changed from recruiting to active, no longer recruiting.
- 12 Apr 2022 Planned primary completion date changed from 20 Dec 2021 to 20 Dec 2022.
- 10 May 2018 New trial record